Modelling Lymphoma Therapy and Outcome

Dose and time intensifications of chemotherapy improved the outcome of lymphoma therapy. However, recent study results show that too intense therapies can result in inferior tumour control. We hypothesise that the immune system plays a key role in controlling residual tumour cells after treatment. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Roesch, Katja, Hasenclever, Dirk, Scholz, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925304/
https://www.ncbi.nlm.nih.gov/pubmed/24338592
http://dx.doi.org/10.1007/s11538-013-9925-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925304/
https://www.ncbi.nlm.nih.gov/pubmed/24338592
http://dx.doi.org/10.1007/s11538-013-9925-3

Ejemplares similares